A newly discovered molecule could reshape the future of weight loss treatments by mimicking the powerful appetite-suppressing ...

GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

The researchers analyzed around 400,000 Reddit posts to find out what patients were saying about the weight loss medications ...

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

Novo Nordisk NOVO.B-0.87%decrease; red down pointing triangle received a warning from the Food and Drug Administration for failing to report serious suspected side effects in patients who took the ...

Radiotherapy is a key foundation of oncologic treatment that is used across the spectrum of cancer indications. Advances in imaging, treatment planning, and dose delivery have led to increasingly ...

I am currently arranging to get a shingles vaccination. I had shingles at university and still bear the scars, so I really don’t want to risk getting it again. But I also have in mind the fact that ...

It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...